Loading…
← Back to schedule
Panel: Biotech’s Strategic Shifts: Therapeutic Priorities Driving Deal-Making
Wednesday April 30, 2025 4:30pm - 5:15pm PDT
Town & Country Ballroom A
Dive into the therapeutic areas and innovation pipelines shaping the biotech industry’s current deal-making priorities, and uncover how companies are positioning themselves for scalable success.

  • Examine how therapeutic advancements in oncology, neurology, and rare diseases are influencing deal-making.
  • Explore the role of precision medicine and emerging modalities in shaping partnership priorities.
  • Learn how biotechs are leveraging R&D pipelines to create competitive differentiation.


Moderators
avatar for Elaine Cheung

Elaine Cheung

Chief Business Officer, Moonwalk Bio
Speakers
avatar for Michelle Chen

Michelle Chen

Chief Business Officer, Insilico Medicine
Michelle Chen, Ph.D., is the Chief Business Officer at Insilico Medicine, a leader in the AI-powered drug discovery and development field. She is responsible for the company’s strategies, corporate development, global business development and the US operations.As a biotech executive... Read More →
avatar for Chris DeRespino

Chris DeRespino

Chief Business Officer, 3T Biosciences
Chris DeRespino serves as chief business officer at 3T Biosciences, an industry leader in pHLA targeting biologics and target discovery. In this role, Mr. DeRespino is responsible for leading G&A functions including business development, finance & human resources. Previously, Mr... Read More →
avatar for Dan Oliver

Dan Oliver

CEO & Co-Founder, Rejuvenate Bio
Wednesday April 30, 2025 4:30pm - 5:15pm PDT
Town & Country Ballroom A Town & Country Resort, 500 Hotel Cir N, San Diego, CA 92108, USA
  Business Development & Licensing

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link